Clinicopathological and molecular characteristics of patients with hypermutant lung cancer: A retrospective cohort study

Tumor mutation burden (TMB) is an independent indicator used to select patients sensitive to immunotherapy. The present study aimed to investigate the clinicopathological and molecular characteristics of patients with hypermutant lung cancer to identify an economical, simple and complementary method...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Hongbin, Wang, Yuan, Ji, Qiaoxia, Cai, Hongmei, Liang, Xiangcun, Xie, Jiong, Li, Hua, Wang, Jun, Zhu, Guiyun, Tian, Erpeng, Zhu, Lingling, Yuan, Mingming, Chen, Rongrong, Zhao, Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7933761/
https://www.ncbi.nlm.nih.gov/pubmed/33692861
http://dx.doi.org/10.3892/ol.2021.12590

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7933761/
https://www.ncbi.nlm.nih.gov/pubmed/33692861
http://dx.doi.org/10.3892/ol.2021.12590

Ejemplares similares